Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
July 3, 2026
Navigating the Grey Zone: A Mixed-Methods Study to Evaluate a Decision Support Tool in the SOGC Late Preterm Antenatal Corticosteroids Guideline
Jessica Liauw, Kayleigh S J Campbell, Madeleine Ennis, et al.
BMC Research Notes
|
July 7, 2022
Halting the Canadian STRIDER randomised controlled trial of sildenafil for severe, early-onset fetal growth restriction: ethical, methodological, and pragmatic considerations
Peter von Dadelszen, François Audibert, Emmanuel Bujold, et al.
Pregnancy Hypertension
|
September 5, 2018
Activated protein C as disease-modifying therapy in antenatal preeclampsia: An open-label, single arm safety and efficacy trial
Peter von Dadelszen, Laura A Magee, Samantha J Benton, et al.
Obstetrics and Gynecology
|
November 9, 2016
Circulating Cell-Free DNA to Determine the Fetal RHD Status in All Three Trimesters of Pregnancy
Kenneth J Moise, Manisha Gandhi, Noemi H Boring, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
July 3, 2026
Navigating the Grey Zone: A Mixed-Methods Study to Evaluate a Decision Support Tool in the SOGC Late Preterm Antenatal Corticosteroids Guideline
Jessica Liauw, Kayleigh S J Campbell, Madeleine Ennis, et al.
BMC Research Notes
|
July 7, 2022
Halting the Canadian STRIDER randomised controlled trial of sildenafil for severe, early-onset fetal growth restriction: ethical, methodological, and pragmatic considerations
Peter von Dadelszen, François Audibert, Emmanuel Bujold, et al.
Pregnancy Hypertension
|
September 5, 2018
Activated protein C as disease-modifying therapy in antenatal preeclampsia: An open-label, single arm safety and efficacy trial
Peter von Dadelszen, Laura A Magee, Samantha J Benton, et al.
Obstetrics and Gynecology
|
November 9, 2016
Circulating Cell-Free DNA to Determine the Fetal RHD Status in All Three Trimesters of Pregnancy
Kenneth J Moise, Manisha Gandhi, Noemi H Boring, et al.
Page
of 4